Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk of heart failure (HF) hospitalizations and cardiovascular mortality among patients with HF and left ventricular ejection fraction (LVEF) ≤40%. There is emerging evidence of the benefits of SGLT2i in HF patients with a higher LVEF (>40%). We aimed to evaluate the benefits of SGLT2i in different subgroups [...]

Background: Sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce the risk of heart failure (HF) hospitalizations and cardiovascular mortality among patients with HF and left ventricular ejection fraction (LVEF) ≤40%. There is emerging evidence of the benefits of SGLT2i in HF patients with a higher LVEF (>40%). We aimed to evaluate the benefits of SGLT2i in different subgroups [...]

Case Presentation: A 53-year-old man with a history of insulin-dependent type 2 diabetes mellitus presented with the complaint of abdominal pain, emesis and poor oral intake for three days. CT scan revealed non-obstructing nephrolithiasis. He was started on continuous IV fluids and pain management. Initial urinalysis revealed glucosuria >1000 mg/dL and negative ketones. Home medications [...]

Case Presentation: A 73yo Caucasian female with history of hypertension, hyperlipidemia, type II diabetes mellitus, and osteoarthritis, presented a few hours after sudden onset, sharp LUQ abdominal pain associated with multiple episodes of nausea and vomiting. Patient denied any previous event like presentation. Further workup revealed no history of pancreatitis, trauma, or alcohol abuse. Medications [...]